ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse
Official Title  Intervention for Low-Income Pregnant Women With Partner Abuse
Brief Summary

This study will evaluate the effectiveness of an interpersonally oriented treatment program called Reach Out for a Safe Environment in preventing depression and post-traumatic stress disorder in low-income pregnant women who have experienced recent partner abuse.

Detailed Description

Each year, approximately 324,000 pregnant women experience partner abuse (PA). With the emotional highs and lows that accompany new motherhood, pregnancy is often a challenging process for many women. Experiencing PA, while already going through a vulnerable time during pregnancy, may have harmful effects on the well-being of the woman and her infant. Women affected by PA are at an increased risk for certain physical and psychological problems, including depression and post-traumatic stress disorder (PTSD). Furthermore, the emotional distress from PA may impair a woman's ability to seek out the necessary support to ensure the safety of herself and her children. There have been few research efforts to develop an effective treatment to reduce the psychological impact of PA on pregnant women and even fewer efforts that target low-income women, who make up a large portion of affected women. The Reach Out for a Safe Environment (ROSE) program is an interpersonally oriented treatment developed to address factors that may contribute to postpartum mental health difficulties associated with PA. This study will evaluate the effectiveness of the ROSE program in preventing depression and PTSD in low-income pregnant women who have experienced recent PA.

Participation in this single-blind study will last approximately 29 weeks. All potential participants will answer an initial questionnaire concerning their history of physical, sexual, or emotional abuse in the past year. Selected participants will then undergo an interview about symptoms of depression, reactions to trauma, emotional difficulties, and alcohol and drug use. Participants invited to continue in the study will then be randomly assigned to the ROSE program or enhanced care as usual (ECU). Participants assigned to the ROSE program will attend four weekly 90-minute group sessions prior to delivery and one individual 50-minute booster session within 4 weeks of delivery. During these sessions, participants will learn ways to manage stress and negative feelings and how to access helpful resources. Participants will also complete two questionnaires about emotional difficulties per week for the duration of the program. Participants assigned to ECU will receive the usual medical care provided for pregnant women and will receive educational material on depression.

All participants will complete questionnaires and interviews about their emotional difficulties, relationships with others, and use of services for these difficulties prior to treatment assignment, 4 weeks after treatment assignment, 4 weeks after delivery, and 3 months after delivery. Participants in the ROSE program will additionally complete a questionnaire about their perceptions of the program after the fourth treatment session and after the booster session.

Study Phase Phase I
Study Type  Interventional
Study Design  Prevention, Randomized, Single Blind (Outcomes Assessor), Uncontrolled, Parallel Assignment
Primary Outcome Measure  Longitudinal Interval Follow-up Examination (LIFE) [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Revised Conflict Tactic Scale (CTS2) [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
Edinburgh Postnatal Depression Scale [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
The Davidson Trauma Scale [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
The Arizona Social Support Interview Schedule [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
Parenting Stress Index [ Time Frame: Measured at Year 1 ] [ Designated as safety issue: No ]
Condition  Depression, Postpartum
Depression
Intervention  Behavioral: The Reach Out for a Safe Environment (ROSE) program
Behavioral: Enhanced care as usual (ECU)
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  60
Start Date  September 2005
Completion Date December 2008
Eligibility Criteria 

Inclusion Criteria:

  • Able to speak and read English sufficiently to complete the study procedures
  • Willing and able to receive public assistance
  • Identified as having experienced physical assault based on responses to CTS2 within 1 year prior to study entry
  • 35 weeks or less gestation

Exclusion Criteria:

  • Meets current criteria for major depressive disorder or post-traumatic stress disorder
Gender Female
Ages 18 Years to 40 Years
Accepts Healthy Volunteers Yes
Contacts ††
Contact: Petra Smith     401-639-2783     psmith@butler.org    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00602732
Organization ID R34 MH075013
Secondary IDs †† DSIR 83-ATP
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Caron Zlotnick, PhD     Butler Hospital    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date February 2008
First Received Date  January 22, 2008
Last Updated Date February 8, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers